The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes

Journal of Nephrology

Volumn 20, Issue 5, 2007, Pages 554-559

  Spoto, Belinda ^a   Parlongo, Rosa M ^a   Parlongo, Giovanna ^a   Sgro, Edoardo ^a   Zoccali, Carmine ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Adipocytes; Adipose tissue; ADMA; DDAH; NOS; PRMT

Indexed keywords

DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PROTEIN ARGININE METHYLTRANSFERASE; AMIDASE; ARGININE; DRUG DERIVATIVE; ISOENZYME; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; ENZYME MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; SUBCUTANEOUS FAT;

ADIPOCYTES; ADOLESCENT; ADULT; AGED; AMIDOHYDROLASES; ARGININE; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRA-ABDOMINAL FAT; ISOENZYMES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PROTEIN-ARGININE N-METHYLTRANSFERASE; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 38149073097     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
2. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-7.
3. Scott HS, Antonarakis SE, Lalioti MD, Rossier C, Silver PA, Henry MF. Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2). Genomics 1998; 48: 330-40.
4. Tang J, Gary JD, Clarke S, Herschman HR. PRMT3, a type I protein arginine N-methyltransferase that differs from PRMT1 and its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 1998; 273: 16935-45.
5. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Asward DW, Stallcup MR. Regulation of transcription by protein methyltransferase. Science 1999; 284: 2174-7.
6. Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, Bedford MT. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 2002; 277: 3537-43.
7. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charlest IG, Whitley GS, Vallance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999; 343: 209-14.
8. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 2005; 16: 2256-61.
9. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competine risk modeling approach. J Am Soc Nephrol 2005; 16: 2254-6.
10. Zoccali C, Bode-Beger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boeger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358:2113-7.
11. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-55.
12. Zoccali C, Mallamaci F, Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int Suppl 2003; 84: S65-8.
13. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 14: 875-80.
14. Ritchie SA, Ewart MA, Perry CG, Connell JM, Salt IP. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond) 2004; 107: 519-32.
15. Schulze F, Schwedhelm E, Maas R, Boger RH. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 831: 333.
16. ΛΛCT method. Methods 2001; 25: 402-8.
17. Clarke S. Protein methylation. Curr Opin Cell Biol 1993; 5: 977-83.
18. Rawal N, Rajpurohit R, Lieschwe MA, Williams KR, Paik WK, Kim S. Structural specificity of substrate for S-adenosylmethionine: protein arginine N-methyltransferases. Biochim Biophys Acta 1995; 1248: 11-8.
19. Gary J, Clarke S. RNA and protein interactions modulated
20. Ogawa T, Kimoto M, Sasaoka K. Occurrence of a new enzyme catalysing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats. Biochem Biophys Res Commun 1987; 148: 671-7.
21. Kimoto M, Whitley GS, Tsuji H, Ogawa T. Detection of NG,NG-dimethyl-L-arginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 1995; 117: 237-8.
22. Tran CT, Fox MF, Vallance P, Leiper J. Chromosomal localization, gene structure and expression pattern of DDAH1: comparison with ddah2 and implications for evolutionary origins. Genomics 2000; 68: 101-5.
23. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-800.
24. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
25. Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 2004; 89: 6277-81.
26. Stuhlinger MC, Abbasi F, Chu JW, Lambendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 20: 1420-6.